Alan L. Chang
Stanford Medicine(US)Stanford University(US)
Publications by Year
Research Areas
Immune cells in cancer, Neuroinflammation and Neurodegeneration Mechanisms, Cancer Immunotherapy and Biomarkers, Chemokine receptors and signaling, Tryptophan and brain disorders
Most-Cited Works
- → Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors(2014)576 cited
- → IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival(2012)463 cited
- → HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma(2019)294 cited
- → Clinical validation of the tempus xT next-generation targeted oncology sequencing assay(2019)228 cited
- → Phosphodiesterase A1, a Regulator of Cellulose Synthesis in Acetobacter xylinum, Is a Heme-Based Sensor(2001)221 cited
- → Consumer Personality and Green Buying Intention: The Mediate Role of Consumer Ethical Beliefs(2013)199 cited
- → Integrated genomic profiling expands clinical options for patients with cancer(2019)191 cited
- → Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis(2014)109 cited
- → The role of IDO in brain tumor immunotherapy(2014)104 cited
- → Multiomics Characterization of Preterm Birth in Low- and Middle-Income Countries(2020)101 cited